EXCLUSIVE PROMOTION SERVICE AGREEMENT WITH KEXING BIOPHARM REGARDING CMAB008 (INFLIXIMAB)Exclusive Promotion Service Agreement • March 31st, 2022
Contract Type FiledMarch 31st, 2022This announcement is made by Mabpharm Limited (the “Company”, together with its subsidiaries, the “Group”) on a voluntary basis to inform the shareholders and potential investors of the Company about the latest business updates of the Group.